Sigyn Therapeutics (SIGY) EBITDA (2017 - 2025)
Sigyn Therapeutics (SIGY) posted EBITDA of -$386,529 for Q3 2025, compared with -$807,095 a year earlier.
Powered by 
Analysis
Sigyn Therapeutics (SIGY) EBITDA (2017 - 2025) Analysis & Trends
For the trailing twelve months through Sep 30, 2025, EBITDA at Sigyn Therapeutics was -$1.88 million; for FY2024, it came in at -$2.51 million.
- In prior years, Sigyn Therapeutics' EBITDA was -$2.45 million in FY2023, -$2.14 million in FY2022, -$1.99 million in FY2021 and -$905,134 in FY2020.
- The Q3 2025 figure stands as the highest quarterly EBITDA since Q4 2020.
- According to Business Quant data, EBITDA for the three prior quarters was -$469,513 (Q2 2025), -$544,696 (Q1 2025) and -$476,647 (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 251.30 Bn | 230.45 Bn | 4.88 Bn | 2.90 Bn |
| 2 | Abbott Laboratories | 174.70 Bn | 145.78 Bn | 7.27 Bn | 2.75 Bn |
| 3 | Danaher | 158.94 Bn | 142.76 Bn | 3.61 Bn | 1.79 Bn |
| 4 | Intuitive Surgical | 145.87 Bn | 125.42 Bn | 1.96 Bn | 1.19 Bn |
| 5 | Medtronic | 111.49 Bn | 77.36 Bn | 6.34 Bn | 2.49 Bn |
| 6 | Stryker | 106.96 Bn | 93.08 Bn | 4.50 Bn | 1.96 Bn |
| 7 | Boston Scientific | 63.62 Bn | 58.63 Bn | 3.85 Bn | 1.53 Bn |
| 8 | Edwards Lifesciences | 50.80 Bn | 34.92 Bn | 1.35 Bn | 555.90 Mn |
| 9 | Becton Dickinson | 49.59 Bn | 46.74 Bn | 2.32 Bn | 1.23 Bn |
| 10 | Sigyn Therapeutics | 64,215.08 | -46,853.92 | - | -386,529.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -386,529.00 |
| Jun 30, 2025 | -469,513.00 |
| Mar 31, 2025 | -544,696.00 |
| Dec 31, 2024 | -476,647.00 |
| Sep 30, 2024 | -807,095.00 |
| Jun 30, 2024 | -601,441.00 |
| Mar 31, 2024 | -628,449.00 |
| Dec 31, 2023 | -715,626.00 |
| Sep 30, 2023 | -640,798.00 |
| Jun 30, 2023 | -571,394.00 |
| Mar 31, 2023 | -518,643.00 |
| Dec 31, 2022 | -468,973.00 |
| Sep 30, 2022 | -531,031.00 |
| Jun 30, 2022 | -530,176.00 |
| Mar 31, 2022 | -606,632.00 |
| Dec 31, 2021 | -588,372.00 |
| Sep 30, 2021 | -572,032.00 |
| Jun 30, 2021 | -437,263.00 |
| Mar 31, 2021 | -391,398.00 |
| Dec 31, 2020 | -334,904.00 |
API Access
Sigyn Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=SIGY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "SIGY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=SIGY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();